Cited by

• Antitumor activity of treosulfan against human breast carcinomas.

  Köpf-Maier P, Sass G. Köpf-Maier P, et al. Cancer Chemother Pharmacol. 1992;31(2):103-10. doi: 10.1007/BF00685095. Cancer Chemother Pharmacol. 1992. PMID: 1451231
• Cyclosporin A potentiation of VP-16: production of long-term survival in murine acute lymphatic leukemia.

  Slater LM, Cho J, Wetzel M. Slater LM, et al. Cancer Chemother Pharmacol. 1992;31(1):53-6. doi: 10.1007/BF00695994. Cancer Chemother Pharmacol. 1992. PMID: 1458558
• Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system.

  Kruczynski A, Vandenberghe I, Pillon A, Pesnel S, Goetsch L, Barret JM, Guminski Y, Le Pape A, Imbert T, Bailly C, Guilbaud N. Kruczynski A, et al. Invest New Drugs. 2011 Feb;29(1):9-21. doi: 10.1007/s10637-009-9328-3. Epub 2009 Sep 24. Invest New Drugs. 2011. PMID: 19777159
• Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.

  Etievant C, Barret JM, Kruczynski A, Perrin D, Hill BT. Etievant C, et al. Invest New Drugs. 1998;16(1):3-17. doi: 10.1023/a:1006022811895. Invest New Drugs. 1998. PMID: 9740539
• Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity.

  Bernhardt G, Reile H, Birnböck H, Spruss T, Schönenberger H. Bernhardt G, et al. J Cancer Res Clin Oncol. 1992;118(1):35-43. doi: 10.1007/BF01192309. J Cancer Res Clin Oncol. 1992. PMID: 1309532 Free PMC article.